75 related articles for article (PubMed ID: 10497148)
1. Isoform-selective metabolism of mianserin by cytochrome P-450 2D.
Chow T; Hiroi T; Imaoka S; Chiba K; Funae Y
Drug Metab Dispos; 1999 Oct; 27(10):1200-4. PubMed ID: 10497148
[TBL] [Abstract][Full Text] [Related]
2. Catalytic specificity of CYP2D isoforms in rat and human.
Hiroi T; Chow T; Imaoka S; Funae Y
Drug Metab Dispos; 2002 Sep; 30(9):970-6. PubMed ID: 12167561
[TBL] [Abstract][Full Text] [Related]
3. Identification of human cytochrome P450 isoforms involved in the stereoselective metabolism of mianserin enantiomers.
Koyama E; Chiba K; Tani M; Ishizaki T
J Pharmacol Exp Ther; 1996 Jul; 278(1):21-30. PubMed ID: 8764331
[TBL] [Abstract][Full Text] [Related]
4. Developmental changes in the catalytic activity and expression of CYP2D isoforms in the rat liver.
Chow T; Imaoka S; Hiroi T; Funae Y
Drug Metab Dispos; 1999 Feb; 27(2):188-92. PubMed ID: 9929501
[TBL] [Abstract][Full Text] [Related]
5. Expression of four rat CYP2D isoforms in Saccharomyces cerevisiae and their catalytic specificity.
Wan J; Imaoka S; Chow T; Hiroi T; Yabusaki Y; Funae Y
Arch Biochem Biophys; 1997 Dec; 348(2):383-90. PubMed ID: 9434752
[TBL] [Abstract][Full Text] [Related]
6. Progesterone oxidation by cytochrome P450 2D isoforms in the brain.
Hiroi T; Kishimoto W; Chow T; Imaoka S; Igarashi T; Funae Y
Endocrinology; 2001 Sep; 142(9):3901-8. PubMed ID: 11517168
[TBL] [Abstract][Full Text] [Related]
7. The ability of cytochrome P450 2D isoforms to synthesize dopamine in the brain: An in vitro study.
Bromek E; Haduch A; Daniel WA
Eur J Pharmacol; 2010 Jan; 626(2-3):171-8. PubMed ID: 19818757
[TBL] [Abstract][Full Text] [Related]
8. Importance of CYP2D3 in polymorphism of diazepam p-hydroxylation in rats.
Sakai N; Saito K; Kim HS; Kazusaka A; Ishizuka M; Funae Y; Fujita S
Drug Metab Dispos; 2005 Nov; 33(11):1657-60. PubMed ID: 16081673
[TBL] [Abstract][Full Text] [Related]
9. Homology modeling of rat and human cytochrome P450 2D (CYP2D) isoforms and computational rationalization of experimental ligand-binding specificities.
Venhorst J; ter Laak AM; Commandeur JN; Funae Y; Hiroi T; Vermeulen NP
J Med Chem; 2003 Jan; 46(1):74-86. PubMed ID: 12502361
[TBL] [Abstract][Full Text] [Related]
10. Tissue distributions of CYP2D1, 2D2, 2D3 and 2D4 mRNA in rats detected by RT-PCR.
Hiroi T; Imaoka S; Chow T; Funae Y
Biochim Biophys Acta; 1998 May; 1380(3):305-12. PubMed ID: 9555068
[TBL] [Abstract][Full Text] [Related]
11. Regional and cellular distribution of CYP2D subfamily members in rat brain.
Miksys S; Rao Y; Sellers EM; Kwan M; Mendis D; Tyndale RF
Xenobiotica; 2000 Jun; 30(6):547-64. PubMed ID: 10923858
[TBL] [Abstract][Full Text] [Related]
12. The roles of amino acid residues at positions 216 and 219 in the structural stability and metabolic functions of rat cytochrome P450 2D1 and 2D2.
Narimatsu S; Kiryu K; Yonemoto R; Yoshino M; Kobatake M; Kazamori D; Hagino S; Masuda K; Katsu T; Asanuma M; Kumamoto T; Ishikawa T; Funae Y; Yamano S; Hanioka N; Naito S
Chem Biol Interact; 2008 Mar; 172(1):11-21. PubMed ID: 18191824
[TBL] [Abstract][Full Text] [Related]
13. The mechanism causing the difference in kinetic properties between rat CYP2D4 and human CYP2D6 in the oxidation of dextromethorphan and bufuralol.
Narimatsu S; Kazamori D; Masuda K; Katsu T; Funae Y; Naito S; Nakura H; Yamano S; Hanioka N
Biochem Pharmacol; 2009 Mar; 77(5):920-31. PubMed ID: 19059219
[TBL] [Abstract][Full Text] [Related]
14. Characterization of cytochrome P-450 2D1 activity in rat brain: high-affinity kinetics for dextromethorphan.
Tyndale RF; Li Y; Li NY; Messina E; Miksys S; Sellers EM
Drug Metab Dispos; 1999 Aug; 27(8):924-30. PubMed ID: 10421620
[TBL] [Abstract][Full Text] [Related]
15. Stereoselective disposition of mianserin is related to debrisoquin hydroxylation polymorphism.
Dahl ML; Tybring G; Elwin CE; Alm C; Andreasson K; Gyllenpalm M; Bertilsson L
Clin Pharmacol Ther; 1994 Aug; 56(2):176-83. PubMed ID: 8062494
[TBL] [Abstract][Full Text] [Related]
16. CYP2D in the brain.
Funae Y; Kishimoto W; Cho T; Niwa T; Hiroi T
Drug Metab Pharmacokinet; 2003; 18(6):337-49. PubMed ID: 15618754
[TBL] [Abstract][Full Text] [Related]
17. Effect of psychotropic drugs on the 21-hydroxylation of neurosteroids, progesterone and allopregnanolone, catalyzed by rat CYP2D4 and human CYP2D6 in the brain.
Niwa T; Okada K; Hiroi T; Imaoka S; Narimatsu S; Funae Y
Biol Pharm Bull; 2008 Mar; 31(3):348-51. PubMed ID: 18310890
[TBL] [Abstract][Full Text] [Related]
18. The endogenous substrates of brain CYP2D.
Wang X; Li J; Dong G; Yue J
Eur J Pharmacol; 2014 Feb; 724():211-8. PubMed ID: 24374199
[TBL] [Abstract][Full Text] [Related]
19. Effects of thioridazine, an inhibitor of CYP2D6, on the steady-state plasma concentrations of the enantiomers of mianserin and its active metabolite, desmethylmianserin, in depressed Japanese patients.
Yasui N; Tybring G; Otani K; Mihara K; Suzuki A; Svensson JO; Kaneko S
Pharmacogenetics; 1997 Oct; 7(5):369-74. PubMed ID: 9352572
[TBL] [Abstract][Full Text] [Related]
20. Hydroxylation and demethylation of the tricyclic antidepressant nortriptyline by cDNA-expressed human cytochrome P-450 isozymes.
Olesen OV; Linnet K
Drug Metab Dispos; 1997 Jun; 25(6):740-4. PubMed ID: 9193876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]